Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial
Year: 2013
Type: article
Study design: Clinical Trial
Institutions: Osaka University Hospital, The University of Osaka, Tokyo Medical University, Fukushima Medical University, Keio University Hospital, Tokai University, Tokai University Hospital, University of Tsukuba, Kumamoto University, Kanazawa University, Kanazawa University Hospital, Wakayama Medical University, Research Institute for Microbial Diseases, The University of Osaka, Alexion Pharmaceuticals (United States), Jichi Medical University, SHOWA Medical University, SHOWA Medical University Fujigaoka Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: eculizumab, paroxysmal nocturnal hemoglobinuria, anti-C5 monoclonal antibody, complement inhibition, intravascular hemolysis, red blood cell transfusion, renal function, quality of life, thromboembolism, infection risk, bone marrow dysfunction, Japanese patients, long-term treatment safety
Open Access status: closed
OpenAlex ID: W1984737284
